Amylyx Pharmaceuticals, Inc. - Common Stock (NQ:AMLX)
14.37
-0.21
(-1.44%)
Streaming Delayed Price
Updated: 10:29 AM EDT, May 14, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 108,692 |
| Open | 14.68 |
| Bid (Size) | 14.33 (200) |
| Ask (Size) | 14.37 (100) |
| Prev. Close | 14.58 |
| Today's Range | 14.13 - 14.71 |
| 52wk Range | 4.200 - 18.61 |
| Shares Outstanding | 67,176,067 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Amylyx (AMLX) Q4 2025 Earnings Call Transcript ↗
March 03, 2026
Apogee Therapeutics Stock Up 100% as Fund Lifts Stake to $28 Million ↗
February 25, 2026
Frequently Asked Questions
Is Amylyx Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Amylyx Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Amylyx Pharmaceuticals, Inc. - Common Stock trade on?
Amylyx Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Amylyx Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Amylyx Pharmaceuticals, Inc. - Common Stock is AMLX on the Nasdaq Stock Market
What is the current price of Amylyx Pharmaceuticals, Inc. - Common Stock?
The current price of Amylyx Pharmaceuticals, Inc. - Common Stock is 14.37
When was Amylyx Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Amylyx Pharmaceuticals, Inc. - Common Stock was at 05/14/26 10:29 AM ET
What is the market capitalization of Amylyx Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Amylyx Pharmaceuticals, Inc. - Common Stock is 965.32M
How many shares of Amylyx Pharmaceuticals, Inc. - Common Stock are outstanding?
Amylyx Pharmaceuticals, Inc. - Common Stock has 965M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.